Furthermore, insulin-like growth factor-1 has been marginally linked to an increased risk of ER+ breast cancer.23 Other circulating biomarkers, such as insulin, leptin, and C-peptide, may also influence breast cancer etiology.24 Here, INS is linked to breast carcinoma.